Skip to Content

Avisa Diagnostics Inc FOGCF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FOGCF is trading at a 111% premium.
Price
$0.00
Fair Value
$8.24
Uncertainty
Extreme
1-Star Price
$4.29
5-Star Price
Economic Moat
Cntf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FOGCF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $4.40
Market Cap
$2.75
Volume/Avg
219,998 / 219,998

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Avisa Diagnostics Inc is a clinical-stage medical device company developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company has established clinical proof-of-concept through trials in cystic fibrosis, tuberculosis and community acquired pneumonia, which demonstrated positive safety and clinical efficacy results. Avisa is planning pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia and plans to submit Investigational Device Exemption applications to the U.S. FDA for these trials.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
3

Valuation

Metric
FOGCF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
FOGCF

Financial Strength

Metric
FOGCF
Quick Ratio
0.04
Current Ratio
0.06
Interest Coverage
−6.50
Quick Ratio
FOGCF

Profitability

Metric
FOGCF
Return on Assets (Normalized)
−510.33%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
FOGCF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesDqryhjzdJdvxxxt$181.3 Bil
SYK
Stryker CorpGysmbbcmjHwgz$127.8 Bil
BSX
Boston Scientific CorpLtblvqlsNkpjvy$111.2 Bil
MDT
Medtronic PLCMgyycfdBpvpxk$107.9 Bil
EW
Edwards Lifesciences CorpVrcltwpwtFqwskdt$53.0 Bil
DXCM
DexCom IncBqjbhxhyljZnp$50.4 Bil
PHG
Koninklijke Philips NV ADRKhfqwvnwlJdwnnb$25.3 Bil
ZBH
Zimmer Biomet Holdings IncCcgndjkzdSfdd$23.9 Bil
ALGN
Align Technology IncTrjzmjxhHkblpfh$19.2 Bil
PODD
Insulet CorpYsykjwrnQxjnqw$12.7 Bil

Sponsor Center